Shorr; Robert

Patent Applications and Registrations

Patent applications and USPTO patent grants for Shorr; Robert.The latest application filed is for "methods and compositions for the treatment of pre-diabetes, diabetes and metabolic syndrome".

Company Profile

7.15.19

Shorr; Robert - Edison NJ
Shorr; Robert - Overbrook Hills PA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods And Compositions For The Treatment Of Pre-diabetes, Diabetes And Metabolic Syndrome App 20220288018 - Shorr; Robert	2022-09-15
Methods and compositions for the treatment of pre-diabetes, diabetes and metabolic syndrome Grant 11,337,960 - Shorr May 24, 2	2022-05-24
Compositions for the Treatment of Metastatic Cancer App 20210000850 - Shorr; Robert ; et al.	2021-01-07
Pharmaceutical Compounds App 20200331931 - Shorr; Robert ; et al.	2020-10-22
Pharmaceutical compounds Grant 10,526,357 - Shorr , et al. J	2020-01-07
Pharmaceutical compounds Grant 10,450,337 - Shorr , et al. Oc	2019-10-22
Pharmaceutical Compounds App 20190119309 - Shorr; Robert ; et al.	2019-04-25
Pharmaceutical compounds Grant 10,179,796 - Shorr , et al. Ja	2019-01-15
Pharmaceutical Compounds App 20180273551 - Shorr; Robert ; et al.	2018-09-27
Methods And Compositions For The Treatment Of Pre-diabetes, Diabetes And Metabolic Syndrome App 20170354640 - Shorr; Robert	2017-12-14
Pharmaceutical Compounds App 20170218003 - Shorr; Robert ; et al.	2017-08-03
Pharmaceutical Compounds App 20170217998 - Shorr; Robert ; et al.	2017-08-03
Pharmaceutical Compounds App 20150322103 - Shorr; Robert ; et al.	2015-11-12
Pharmaceutical and diagnostic compositions containing nanoparticles useful for treating targeted tissues and cells Grant 7,521,066 - Shorr , et al. April 21, 2	2009-04-21
Pharmaceutical and diagnostic compositions containing nanoparticles useful for treating targeted tissues and cells Grant 7,387,790 - Shorr , et al. June 17, 2	2008-06-17
Pharmaceutical and diagnostic compositions containing nanoparticles useful for treating targeted tissues and cells App 20070203166 - Shorr; Robert ; et al.	2007-08-30
Pharmaceutical and diagnostic compositions containing nanoparticles useful for treating targeted tissues and cells Grant 7,220,428 - Shorr , et al. May 22, 2	2007-05-22
Pharmaceutical and diagnostic compositions containing nanoparticles useful for treating targeted tissues and cells App 20050112207 - Shorr, Robert ; et al.	2005-05-26
Prostacyclin derivative containing compositions and methods of using the same for the treatment of cancer Grant 6,803,386 - Shorr , et al. October 12, 2	2004-10-12
Single-chain antigen-binding proteins capable of glycosylation, production and uses thereof Grant 6,743,908 - Filpula , et al. June 1, 2	2004-06-01
Single-chain antigen-binding proteins capable of glycosylation, production and uses thereof Grant 6,743,896 - Filpula , et al. June 1, 2	2004-06-01
Prostacyclin derivative containing compositions and methods of using the same for the treatment of cancer App 20030166728 - Shorr, Robert ; et al.	2003-09-04
Modified prostaglandin compounds and analogs thereof, compositions containing the same useful for the treatment of cancer App 20030108512 - Shorr, Robert ; et al.	2003-06-12
Pharmaceutical and diagnostic compositions containing nanoparticles useful for treating targeted tissues and cells App 20030017197 - Shorr, Robert ; et al.	2003-01-23
Water-soluble polymer conjugates of triazine derivatives App 20020182172 - Bentley, Michael David ; et al.	2002-12-05
Single-chain antigen-binding proteins capable of glycosylation, production and uses thereof App 20020161201 - Filpula, David ; et al.	2002-10-31
Single-chain antigen-binding proteins capable of glycosylation, production and uses thereof App 20020155498 - Filpula, David ; et al.	2002-10-24
Single-chain antigen-binding proteins capable of glycosylation, production and uses thereof Grant 6,323,322 - Filpula , et al. November 27, 2	2001-11-27
Antigen-binding fusion proteins Grant 5,767,260 - Whitlow , et al. June 16, 1	1998-06-16
Antigen-binding fusion proteins Grant 5,763,733 - Whitlow , et al. June 9, 1	1998-06-09
Chromatographic stationary supports Grant 5,153,166 - Jain , et al. October 6, 1	1992-10-06
Electrophoretic media Grant 5,055,517 - Shorr , et al. October 8, 1	1991-10-08

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.